906 related articles for article (PubMed ID: 31292246)
1. Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.
Wolfisberg R; Holmbeck K; Nielsen L; Kapoor A; Rice CM; Bukh J; Scheel TKH
J Virol; 2019 Oct; 93(19):. PubMed ID: 31292246
[TBL] [Abstract][Full Text] [Related]
2. Viral persistence, liver disease, and host response in a hepatitis C-like virus rat model.
Trivedi S; Murthy S; Sharma H; Hartlage AS; Kumar A; Gadi SV; Simmonds P; Chauhan LV; Scheel TKH; Billerbeck E; Burbelo PD; Rice CM; Lipkin WI; Vandegrift K; Cullen JM; Kapoor A
Hepatology; 2018 Aug; 68(2):435-448. PubMed ID: 28859226
[TBL] [Abstract][Full Text] [Related]
3. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
Hartlage AS; Walker CM; Kapoor A
J Virol; 2020 May; 94(10):. PubMed ID: 32102885
[TBL] [Abstract][Full Text] [Related]
4. Neutralization and receptor use of infectious culture-derived rat hepacivirus as a model for HCV.
Wolfisberg R; Thorselius CE; Salinas E; Elrod E; Trivedi S; Nielsen L; Fahnøe U; Kapoor A; Grakoui A; Rice CM; Bukh J; Holmbeck K; Scheel TKH
Hepatology; 2022 Nov; 76(5):1506-1519. PubMed ID: 35445423
[TBL] [Abstract][Full Text] [Related]
5. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
[TBL] [Abstract][Full Text] [Related]
6. The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control.
Bukh J
J Hepatol; 2016 Oct; 65(1 Suppl):S2-S21. PubMed ID: 27641985
[TBL] [Abstract][Full Text] [Related]
7. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
J Virol; 2019 May; 93(10):. PubMed ID: 30842319
[TBL] [Abstract][Full Text] [Related]
8. Dominant negative effect of wild-type NS5A on NS5A-adapted subgenomic hepatitis C virus RNA replicon.
Graziani R; Paonessa G
J Gen Virol; 2004 Jul; 85(Pt 7):1867-1875. PubMed ID: 15218171
[TBL] [Abstract][Full Text] [Related]
9. Development of full-length cell-culture infectious clone and subgenomic replicon for a genotype 3a isolate of hepatitis C virus.
Chen M; Xu Y; Li N; Yin P; Zhou Q; Feng S; Wu T; Wei L; Wang H; Fu Y; Li YP
J Gen Virol; 2021 Dec; 102(12):. PubMed ID: 34949310
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of in vitro replication-enhancing mutations of the hepatitis C virus (HCV) replicon in patients with chronic HCV infection.
Sarrazin C; Mihm U; Herrmann E; Welsch C; Albrecht M; Sarrazin U; Traver S; Lengauer T; Zeuzem S
J Infect Dis; 2005 Nov; 192(10):1710-9. PubMed ID: 16235168
[TBL] [Abstract][Full Text] [Related]
11. Establishment of robust HCV genotype 4d, 5a, and 6a replicon systems.
Camus G; Xu S; Han B; Lu J; Dvory-Sobol H; Yu M; Cheng G; Miller MD; Doehle BP; Mo H
Virology; 2018 Jan; 514():134-141. PubMed ID: 29175627
[TBL] [Abstract][Full Text] [Related]
12. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a replicon-based phenotypic assay for assessing HCV NS4B from clinical isolates.
Rajyaguru S; Yang H; Martin R; Miller MD; Mo H
Antiviral Res; 2013 Nov; 100(2):328-36. PubMed ID: 24013002
[TBL] [Abstract][Full Text] [Related]
14. Robust and persistent replication of the genotype 6a hepatitis C virus replicon in cell culture.
Yu M; Peng B; Chan K; Gong R; Yang H; Delaney W; Cheng G
Antimicrob Agents Chemother; 2014 May; 58(5):2638-46. PubMed ID: 24550344
[TBL] [Abstract][Full Text] [Related]
15. Development of robust genotype 1a hepatitis C replicons harboring adaptive mutations for facilitating the antiviral drug discovery and study of virus replication.
Lin HM; Wu PS; Hu HS; Chang WC; Wu RH; Tian JN; Chern JH; Yueh A
J Virol Methods; 2018 Sep; 259():10-17. PubMed ID: 29782889
[TBL] [Abstract][Full Text] [Related]
16. Resistance analysis and characterization of NITD008 as an adenosine analog inhibitor against hepatitis C virus.
Qing J; Luo R; Wang Y; Nong J; Wu M; Shao Y; Tang R; Yu X; Yin Z; Sun Y
Antiviral Res; 2016 Feb; 126():43-54. PubMed ID: 26724382
[TBL] [Abstract][Full Text] [Related]
17. Restoration of the activated Rig-I pathway in hepatitis C virus (HCV) replicon cells by HCV protease, polymerase, and NS5A inhibitors in vitro at clinically relevant concentrations.
Kalkeri G; Lin C; Gopilan J; Sloan K; Rijnbrand R; Kwong AD
Antimicrob Agents Chemother; 2013 Sep; 57(9):4417-26. PubMed ID: 23836176
[TBL] [Abstract][Full Text] [Related]
18. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.
Ikeda M; Yi M; Li K; Lemon SM
J Virol; 2002 Mar; 76(6):2997-3006. PubMed ID: 11861865
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus.
Bilello JP; Lallos LB; McCarville JF; La Colla M; Serra I; Chapron C; Gillum JM; Pierra C; Standring DN; Seifer M
Antimicrob Agents Chemother; 2014 Aug; 58(8):4431-42. PubMed ID: 24867983
[TBL] [Abstract][Full Text] [Related]
20. Trans-complementation of HCV replication by non-structural protein 5A.
Tong X; Malcolm BA
Virus Res; 2006 Feb; 115(2):122-30. PubMed ID: 16146661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
